C. Jacobs

发表

Are adjuvant bisphosphonates now standard of care of women with early stage breast cancer? A debate from the Canadian Bone and the Oncologist New Updates meeting

M. Clemons, E. Amir, A. Paterson, 2015, Journal of bone oncology.

Treatment of taxane acute pain syndrome (TAPS) in cancer patients receiving taxane-based chemotherapy—a systematic review

B. Hutton, M. Clemons, Stephanie Smith, 2016, Supportive Care in Cancer.

A Systematic Review of the Incidence and Risk Factors for Taxane Acute Pain Syndrome in Patients Receiving Taxane‐Based Chemotherapy for Prostate Cancer

B. Hutton, M. Clemons, S. Mazzarello, 2017, Clinical genitourinary cancer.

Taxane acute pain syndrome (TAPS) in patients receiving taxane-based chemotherapy for breast cancer—a systematic review

B. Hutton, M. Clemons, S. Mazzarello, 2016, Supportive Care in Cancer.

Management of urogenital atrophy in breast cancer patients: a systematic review of available evidence from randomized trials

B. Hutton, M. Clemons, Stephanie Smith, 2015, Breast Cancer Research and Treatment.

Enhancing accrual to chemotherapy trials for patients with early stage triple-negative breast cancer: a survey of physicians and patients

M. Brackstone, B. Hutton, M. Clemons, 2017, Supportive Care in Cancer.

Pharmacotherapy of bone metastases in breast cancer patients – an update

M. Clemons, C. Addison, M. Ibrahim, 2014, Expert opinion on pharmacotherapy.

A randomized, double-blind, phase II, exploratory trial evaluating the palliative benefit of either continuing pamidronate or switching to zoledronic acid in patients with high-risk bone metastases from breast cancer

D. Cella, G. Dranitsaris, M. Clemons, 2015, Breast Cancer Research and Treatment.

Should de-escalation of bone-targeting agents be standard of care for patients with bone metastases from breast cancer? A systematic review and meta-analysis.

M. Clemons, B. Hutton, S. Mazzarello, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Strategies for obtaining bone biopsy specimens from breast cancer patients – Past experience and future directions

M. Clemons, C. Addison, J. Werier, 2016, Journal of bone oncology.

Long-term benefits versus side-effects from bone-targeted therapies for cancer patients: minimizing risk while maximizing benefits

M. Clemons, C. Jacobs, M. Ong, 2014, Current opinion in supportive and palliative care.

Optimisation of steroid prophylaxis schedules in breast cancer patients receiving docetaxel chemotherapy—a survey of health care providers and patients

Lori A. Eggert, B. Hutton, M. Clemons, 2015, Supportive Care in Cancer.

Is there a role for oral or intravenous ascorbate (vitamin C) in treating patients with cancer? A systematic review.

B. Hutton, M. Clemons, C. Jacobs, 2015, The oncologist.

Clinical Practice Guidelines and Consensus Statements in Oncology – An Assessment of Their Methodological Quality

B. Hutton, M. Clemons, I. Graham, 2014, PloS one.

Definition and consequences of locally advanced breast cancer

M. Clemons, O. Ginsburg, C. Jacobs, 2014, Current opinion in supportive and palliative care.

Defining optimal control of chemotherapy-induced nausea and vomiting—based on patients’ experience

G. Dranitsaris, B. Hutton, M. Clemons, 2015, Supportive Care in Cancer.

Issues Affecting the Loco‐regional and Systemic Management of Patients with Invasive Lobular Carcinoma of the Breast

M. Clemons, C. Addison, A. Arnaout, 2016, The breast journal.

Treatment choices for patients with invasive lobular breast cancer: a doctor survey.

J. Caudrelier, B. Hutton, M. Clemons, 2015, Journal of evaluation in clinical practice.

Thoughts on Jim Flaherty. When should physicians retire?

M. Clemons, C. Jacobs, 2014, Current oncology.

Publishing clinical research: ten pearls for oncology trainees and junior oncologists.

C Jacobs, M Clemons, S Mazzarello, 2014, Current oncology.

Bone-targeted therapy use in patients with bone metastases from lung cancer: A systematic review of randomized controlled trials.

B. Hutton, M. Clemons, C. Jacobs, 2016, Cancer treatment reviews.

Will oncologists applaud the Paris Accord? Time to rethink global mega-conferences.

M. Clemons, A. Joy, C. Jacobs, 2016, Current oncology.

Treatment for locally advanced breast cancer: a global challenge, personalized medicine or both?

M. Clemons, C. Jacobs, D. Simos, 2014, Current opinion in supportive and palliative care.

Lost in transition? Thoughts on retirement--"will you still need me, will you still feed me, when i'm sixty-four?".

M. Clemons, L. Vandermeer, C. Jacobs, 2013, The oncologist.

CANTATA: Randomized, international, double-blind study of CB-839 plus cabozantinib versus cabozantinib plus placebo in patients with metastatic renal cell carcinoma.

R. Figlin, R. Motzer, T. Choueiri, 2019, Journal of Clinical Oncology.

Issues Affecting the Loco‐regional and Systemic Management of Patients with Invasive Lobular Carcinoma of the Breast

M. Clemons, C. Addison, A. Arnaout, 2016, The Breast Journal.

Third-party online surveys-science, selling, or sugging?

M. Clemons, I. Graham, A. Joy, 2015, Current oncology.

Oncologist heal thyself: hallmarks of happiness.

M. Clemons, A. Joy, C. Jacobs, 2015, Current oncology.

Should de-escalation of bone-targeting agents be standard of care for patients with bone metastases from breast cancer? A systematic review and meta-analysis.

B. Hutton, M. Clemons, B. Hutton, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Taxane acute pain syndrome (TAPS) in patients receiving taxane-based chemotherapy for breast cancer—a systematic review

B. Hutton, M. Clemons, S. Mazzarello, 2016, Supportive Care in Cancer.